GTx   Report issue

For profit Phase 2 Phase 3
Founded: Memphis TN United States (1997)
Status: Acquired by Oncternal Therapeutics (2019)

Organization Overview

First Clinical Trial
2001
NCT00028353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GTx